$696.16K in average volume shows that Zymeworks BC Inc (ZYME) is heading in the right direction

On Tuesday, Zymeworks BC Inc (NASDAQ: ZYME) opened higher 4.70% from the last session, before settling in for the closing price of $13.30. Price fluctuations for ZYME have ranged from $6.45 to $13.40 over the past 52 weeks.

During the last 5-year period, the sales growth of Healthcare Sector giant was 264.10%. Company’s average yearly earnings per share was noted 35.59% at the time writing. With a float of $84.22 million, this company’s outstanding shares have now reached $86.45 million.

Let’s determine the extent of company efficiency that accounts for 277 employees. In terms of profitability, gross margin is -49.01%, operating margin of -191.47%, and the pretax margin is -184.96%.

Zymeworks BC Inc (ZYME) Insider Activity

A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Zymeworks BC Inc is 2.59%, while institutional ownership is 79.85%. The most recent insider transaction that took place on Jan 05 ’24, was worth 193,849. In this transaction Chair & CEO of this company sold 18,198 shares at a rate of $10.65, taking the stock ownership to the 29,468 shares. Before that another transaction happened on Jan 08 ’24, when Company’s Chair & CEO sold 5,706 for $11.22, making the entire transaction worth $63,996. This insider now owns 23,762 shares in total.

Zymeworks BC Inc (ZYME) Earnings and Forecasts

According to the Wall Street analysts, stocks earnings will be around 35.59% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 11.00% during the next five years compared to -6.52% drop over the previous five years of trading.

Zymeworks BC Inc (NASDAQ: ZYME) Trading Performance Indicators

Check out the current performance indicators for Zymeworks BC Inc (ZYME). In the past quarter, the stock posted a quick ratio of 7.01. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 19.20.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.52, a number that is poised to hit -0.40 in the next quarter and is forecasted to reach -1.18 in one year’s time.

Technical Analysis of Zymeworks BC Inc (ZYME)

Looking closely at Zymeworks BC Inc (NASDAQ: ZYME), its last 5-days average volume was 0.44 million, which is a drop from its year-to-date volume of 0.64 million. As of the previous 9 days, the stock’s Stochastic %D was 94.96%. Additionally, its Average True Range was 0.44.

During the past 100 days, Zymeworks BC Inc’s (ZYME) raw stochastic average was set at 98.03%, which indicates a significant increase from 94.39% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 26.72% in the past 14 days, which was lower than the 35.88% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $11.82, while its 200-day Moving Average is $10.43. However, in the short run, Zymeworks BC Inc’s stock first resistance to watch stands at $14.20. Second resistance stands at $14.47. The third major resistance level sits at $14.90. If the price goes on to break the first support level at $13.50, it is likely to go to the next support level at $13.07. Should the price break the second support level, the third support level stands at $12.80.

Zymeworks BC Inc (NASDAQ: ZYME) Key Stats

There are currently 70,705K shares outstanding in the company with a market cap of 1.20 billion. Presently, the company’s annual sales total 76,010 K according to its annual income of -118,670 K. Last quarter, the company’s sales amounted to 19,240 K and its income totaled -37,690 K.